Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis
Clinical trial NCT01086410 · COMPLETED
Trial details
- NCT number
- NCT01086410
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-09-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.